Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.31 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.31 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.31 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6797609 | 0.78 | SIGMAR1 (0.36) | SIGMAR1PARP10PARP11THRBTGFBR1 | |
| Trifluoroacetic Acid SCHEMBL6794758 | 0.76 | KDM1A (0.34) | — | |
| Trifluoroacetic Acid SCHEMBL6791557 | 0.73 | MAPKAPK2 (0.33) | PARP10PARP11 | |
| Trifluoroacetic Acid SCHEMBL6793152 | 0.72 | GRM5 (0.31) | — | |
| SCHEMBL4260846 | 0.71 | SIGMAR1 (0.36) | SIGMAR1PARP10PARP11 | |
| Trifluoroacetic Acid SCHEMBL4267636 | 0.71 | AR (0.32) | HRH4HRH3 | |
| Trifluoroacetic Acid SCHEMBL4270922 | 0.71 | MAPKAPK2 (0.36) | — | |
| SCHEMBL6791724 | 0.71 | CNR1 (0.34) | SIGMAR1PARP10PARP11THRBTGFBR1 | |
| Trifluoroacetic Acid SCHEMBL4260056 | 0.71 | KDM1A (0.37) | — | |
| Trifluoroacetic Acid SCHEMBL6794975 | 0.70 | PIM1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | SIGMAR1 4084/4885HRH4 2096/4885HRH3 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.